IL17A and colorectal carcinoma: In a recent study on the effect of IL17A promoter polymorphism on the risk of CRC, the authors found that the A/A-genotype caused a significantly higher susceptibility to the disease in individuals of the Malaysian population, and no associations with clinical and histological features of patients [32].